From the Guidelines
Neither azithromycin nor amoxicillin is likely to be effective against an E. coli infection resistant to ampicillin, sulbactam, and cefazolin. This pattern of resistance suggests the bacteria may produce extended-spectrum beta-lactamase (ESBL) enzymes, which would render both amoxicillin (a beta-lactam antibiotic similar to ampicillin) and azithromycin ineffective, as noted in guidelines for managing complicated intra-abdominal infections 1. Amoxicillin would be ineffective due to cross-resistance with ampicillin, as they belong to the same antibiotic class. Azithromycin generally has poor activity against E. coli even without resistance mechanisms.
For such resistant infections, alternative antibiotics like carbapenems (meropenem, ertapenem), certain fluoroquinolones (if susceptible), or aminoglycosides would be more appropriate choices, considering the recommendations for empiric treatment of community-acquired intra-abdominal infection 1. However, the use of agents like aminoglycosides is not recommended for routine use in adults with community-acquired intra-abdominal infection due to their toxicity 1.
Key considerations for selecting an appropriate antibiotic include:
- The pattern of resistance exhibited by the E. coli strain
- Local microbiologic data
- Cost advantage
- Allergies
- Formulary availability
- The potential for resistance to commonly prescribed agents, as highlighted by the concern over quinolone-resistant E. coli and the increasing antimicrobial resistance among B. fragilis isolates 1
Treatment should always be guided by complete antibiotic susceptibility testing to determine which medications will be effective against the specific resistant strain, emphasizing the importance of obtaining culture and sensitivity results before selecting definitive antibiotic therapy for resistant infections.
From the Research
E. coli Resistance to Ampicillin, Sulbactam, and Cefazolin
- The patient's E. coli infection is resistant to ampicillin, sulbactam, and cefazolin, which are commonly used antibiotics to treat E. coli infections 2, 3, 4.
- Studies have shown that E. coli strains resistant to ampicillin and sulbactam may also be resistant to other beta-lactam antibiotics, such as cefazolin 5, 4.
Effectiveness of Azithromycin and Amoxicillin
- Azithromycin is a macrolide antibiotic that is not typically used to treat E. coli infections, as E. coli is often resistant to macrolides 4.
- Amoxicillin is a beta-lactam antibiotic that is similar to ampicillin, and its effectiveness against E. coli strains resistant to ampicillin and sulbactam is uncertain 2, 3.
- One study found that amoxicillin-clavulanic acid (a combination of amoxicillin and a beta-lactamase inhibitor) had activity against some E. coli strains resistant to ampicillin and sulbactam, but the effectiveness of amoxicillin alone is unclear 2, 5.
Alternative Treatment Options
- Other antibiotics, such as fosfomycin, nitrofurantoin, or fluoroquinolones, may be effective against E. coli strains resistant to ampicillin, sulbactam, and cefazolin 4.
- The choice of antibiotic should be based on the results of antimicrobial susceptibility testing and the patient's clinical condition 4, 6.